Acrivon Therapeutics, Inc.'s total assets for Q1 2026 were $107.83M, a decrease of -16.87% from the previous quarter. ACRV total liabilities were $12.32M for the fiscal quarter, a -28.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.